Episode 24 · GxP Conversations

MHRA Guidance Note 6: wholesale distribution

Join Kyle and Adam as they discuss wholesale distribution and broker registration.

22:03Published 08 July 2026
MHRA Guidance Note 6: wholesale distribution22:03

Opens in a new tab. Keep this page for the lesson notes and related learning.

Subject notes

Subject notes: identify the activity before the authorisation

MHRA Guidance Note 6 explains wholesale distribution and broker registration for human medicines. These notes provide subject context rather than an account of the conversation. Begin with what the business actually does: who buys, owns, holds, supplies or independently negotiates for another party.

The MHRA distinguishes brokering from wholesale dealing. Its broker guidance describes independent negotiation on another company's behalf without buying, selling, owning or physically handling the products. Guidance Note 6 also covers wholesale operations that do not physically handle medicines, so absence of a warehouse does not settle the classification.

Practice example: draw two parallel routes

Imagine a business arranging a medicine's movement through an external warehouse. Draw one route for the product and another for the orders, invoices and transfer of ownership. Mark each organisation's role and the evidence supporting it. Where the two routes differ, identify who can explain the arrangement.

Use the diagram to prepare questions for the appropriate licensing and quality specialists. The exercise is useful before entering a new arrangement because commercial descriptions such as agent or logistics partner may not explain the regulated activity being performed.

Questions to resolve before a new arrangement

Check the current MHRA guidance and the actual authorisation or registration scope against the proposed activity.

  • Which legal entity performs each activity, and where does it happen?
  • What authorisation or registration evidence supports the proposed business model?
  • Who owns quality decisions and communication with outsourced providers?
  • How would a complaint, recall or suspected falsified product be escalated?

Official guidance and further reading

Subject notes support further learning; they are not a transcript. Check current guidance and approved procedures for your work.

Continue the conversation.

Hosted by Help Me GxP co-creators Kyle Winn and Adam Walker. Explore the full series for conversations about pharmaceutical quality, GMP, GDP and the guidance behind everyday practice.

Episodes reflect the material discussed at the time of recording. Check the current official guidance for the requirements that apply to your work.

Browse more podcast episodes or explore our guidance and reference hub.